for in vivo cross-presentation in mice.
Certainly, many immunologic phenomena may be explained by differential involvement of DC subsets, but in this case, two alternative explanations more likely explain the findings of Segura et al. (4) . First, Segura et al. (4) reported that splenic CD8 + DCs do not express the MR and thus, cannot use it for ovalbumin (OVA) uptake. This statement was reached using splenic DCs isolated by collagenase digestion, which were subsequently exposed to OVA. However, collagen fragments are MR ligands (5). The massive amounts of such fragments, which are inevitably generated during collagenase digestion, bind the MR and cause its internalization. Segura et al. (4) stained for MR expression on the DC surface and thus, failed to detect intracellular MR. We had previously used intracellular staining and detected the MR within splenic DCs (2). Splenic DCs did endocytose OVA through the MR when we used a collagenasefree DC isolation technique (Fig. 1) . Moreover, MR-mediated endocytosis by bone marrow-derived DCs was abolished when lysates from collagenase-digested spleens were added, confirming their ability to block the MR (Fig. 1) . Second, antigen dose is a major determinant of immunity. Previously, we had injected mice with 0.1 mg OVA and showed that the absence of the MR reduced cross-presentation severely, albeit not completely (1). This confirmed its dominant role in cross-presentation of OVA and indicated the existence of other uptake mechanisms. Segura et al. (4) injected 2 mg, which is 20-fold higher than our dose. Under these conditions, cross-presentation was MR-independent, also in our experimental setup (Fig. 2) . However, less unphysiologic doses depended on the MR (Fig. 2) . Moreover, commercially available OVA preparations usually contain contaminating fragments, which may be internalized by other mechanisms or may bind directly as peptides to surface MHC-I without intracellular processing. To avoid this problem, we had always removed OVA fragments by gel filtration. Presentation of unpurified OVA contaminated with such fragments is MR-independent (Fig. 2) .
In summary, studying the role of the MR receptor in crosspriming requires (i) DC isolation by techniques that do not employ collagenase digestion, (ii) clean OVA free of contaminating fragments, and (iii) avoidance of antigen in excessive doses. We conclude that not only inflammatory but also steady-state cross-presentation of OVA is partially MR-dependent. The authors declare no conflict of interest.
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To whom correspondence may be addressed. E-mail: sven.burgdorf@ukb.uni-bonn.de or ckurts@web.de. Fig. 2 . Importance of antigen dose and purity for investigating MRdependent cross-presentation. For the in vivo experiments, wild-type or MRdeficient mice were injected with 1.5 × 10 6 carboxyfluorescein succinimidyl ester (CFSE)-labeled OVA-specific CD8+ T cells (OT-I). After 16 hours, mice were challenged with the indicated amounts of crude or gel-filtrated OVA. After another 48 hours, proliferation of OT-I cells was analyzed by flow cytometry. Graphs depict mean division index ± SEM. For the ex vivo experiments, splenic DCs were isolated without using collagenase; 10 5 DCs were incubated with the indicated amounts of OVA and 1.5 ± 10 5 OT-I cells. IL-2 secretion in the supernatant was determined by ELISA after 24 hours. Graphs depict mean IL-2 secretion ± SEM. Gel filtration of OVA solutions was performed using PD10 columns (GE Healthcare). Fig. 1 . Collagenase digestion products block MR-mediated antigen uptake. (Upper) Splenic DCs from wild-type or MR-deficient mice were isolated by using collagenase digestion for 30 minutes at 37°C or mashing spleen fragments without collagenase followed by a CD11c-based magnetic separation (Miltenyi Biotec). Subsequently, cells were plated and incubated with 1 μg/mL fluorochrome-labeled OVA for 20 minutes at 37°C. (Lower) Bone marrowderived DCs (BM-DCs) were generated as described before (1) and preincubated with a 10-fold dilution of spleen lysates after collagenase digestion. After 15 minutes, 1 μg/mL fluorochrome-labeled OVA was added for another 20 minutes. Internalization of OVA was monitored by flow cytometry.
